Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative Management of Endometrial Cancer and Atypical Hyperplasia
2010-018581-23Phase 2Active
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of avatrombopag in endometrial cancer (EC) and Endometrial intraepithelial neoplasia (EIN), sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoints: Recurrence-free rate and Morbidity. Started Dec 2010; status: active.
02
Drugs
avatrombopag
03
Conditions
endometrial cancer (EC)Endometrial intraepithelial neoplasia (EIN)
Beyond the preview
Go deeper on 2010-018581-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018581-23.